David A. Amato
- Experimental and Cognitive Psychology top 1%
- Cognitive Neuroscience top 2%
- Immunology top 5%
- Endocrine and Autonomic Systems top 1%
- Oncology top 5%
- Co-authors
- Judy CaronThomas RothThomas WesselAndrew D. KrystalRobert RubensJames K. WalshMasanori ShirakiW. Vaughn McCall
- Topics
- Sleep and related disorders (12 papers)Psoriasis: Treatment and Pathogenesis (8 papers)Sleep and Wakefulness Research (8 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David A. Amato
50 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Experimental and Cognitive Psychology 1.0k
- Cognitive Neuroscience 945
- Immunology 861
- Endocrine and Autonomic Systems 514
- Oncology 488
Countries citing papers authored by David A. Amato
This map shows the geographic impact of David A. Amato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Amato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Amato more than expected).
Fields of papers citing papers by David A. Amato
This network shows the impact of papers produced by David A. Amato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Amato. The network helps show where David A. Amato may publish in the future.
Co-authorship network of co-authors of David A. Amato
This figure shows the co-authorship network connecting the top 25 collaborators of David A. Amato. A scholar is included among the top collaborators of David A. Amato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Amato. David A. Amato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 1 | |
| 3 | Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasisbreakdown → | 650 |
| 4 | 43 | |
| 5 | 24 | |
| 6 | Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial. | 20 |
| 7 | 33 | |
| 8 | 71 | |
| 9 | 167 | |
| 10 | 320 | |
| 11 | 86 | |
| 12 | 43 | |
| 13 | 105 | |
| 14 | 3 | |
| 15 | 312 | |
| 16 | 23 | |
| 17 | 71 | |
| 18 | 65 | |
| 19 | 50 | |
| 20 | 21 |
About David A. Amato
David A. Amato is a scholar working on Experimental and Cognitive Psychology, Dermatology and Endocrine and Autonomic Systems, having authored 51 papers that have together received 3.3k indexed citations. Recurring topics across this work include Sleep and related disorders (12 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Sleep and Wakefulness Research (8 papers). The work is most often cited by research in Experimental and Cognitive Psychology (1.0k citations), Endocrine and Autonomic Systems (514 citations) and Dermatology (464 citations). David A. Amato has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Judy Caron, Thomas Roth, Thomas Wessel, Andrew D. Krystal, Robert Rubens, James K. Walsh, Masanori Shiraki, W. Vaughn McCall, Ernest C. Borden and Eugene Laska. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.